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INTRODUCTION
Acute Kidney Injury (AKI) caused by a radio-contrast dye
or Contrast Induced Nephropathy (CIN) is a common
complication of coronary angiography.1 Despite advances
in preventive measures, CIN is the third leading cause of
AKI and is associated with higher rates of morbidity and
mortality in hospitalized patients, with a more compli-
cated and longer in-hospital stay.2-4 The incidence of
acute kidney injury in, otherwise healthy individuals
undergoing coronary angiography has been reported to
be as low as 2%. However, in high risk patients with
inadequate prophylaxis, the frequency of developing
CIN can be as high as 80%.2,5
Chronic kidney disease (CKD) is the most significant risk
factor for CIN and multiple studies have shown that it
is an independent risk predictor for CIN.3,4,6 Several
prophylactic measures have been tested to prevent
kidney injury after contrast exposure. The most studied
ones are hydration, sodium bicarbonate infusion, anti-
oxidants such as N-acetyl-cysteine and ascorbic acid,
and lately statins.7-10 Among these, peri-procedure
hydration with normal saline has been proven to be most
effective.7
Unfortunately, there is no definite definition of CIN. Most
studies have used 0.3-0.5 mg/dl rise in creatinine as a
cutoff for defining CIN.11 Although studies have shown
association of CIN with adverse patient outcomes,1-3
data on actual incidence of 'clinically significant CIN' in
patients undergoing non-emergent cardiac intervention
and its impact on cost of health care is scarce, especially
from this region of the world.
The aim of this study was to evaluate the frequency and
associated risk factors for 'clinically significant' CIN in
high risk patients undergoing non-emergent coronary
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ABSTRACT
Objective: To evaluate the frequency and risk factors associated with clinically significant contrast-induced nephropathy
(CIN) in patients undergoing non-emergent coronary angiography. 
Study Design: Descriptive study.
Place and Duration of Study: The Aga Khan University Hospital, Karachi, from January 2005 to December 2007.
Methodology: Case records of patients who underwent coronary angiography with a serum creatinine of ≥ 1.5 mg/dl at
the time of procedure were evaluated. Clinically significant contrast induced nephropathy (CSCIN) was defined as either
doubling of serum creatinine from baseline value within a week following the procedure or need for emergency
hemodialysis after the procedure.
Results: One hundred and sixteen patients met the inclusion criteria. Mean age was 64.0 ± 11.5 years, 72% were males.
Overall prevalence of CIN was 17% (rise of serum creatinine by ≥ 0.5 mg/dl) while that of clinically significant CIN (CSCIN)
was 9.5% (11 patients). Patients with CSCIN had significantly lower left ventricular ejection fraction (p = 0.03, OR: 0.24;
95% CI = 0.06 – 0.91) and higher prevalence of cerebrovascular disease (p < 0.001, OR: 14.66; 95% CI = 3.30 – 65.08).
Mean baseline serum creatinine was significantly higher, 3.0 ± 1.5 vs. 2.0 ± 1.1 mg/dl (p = 0.03, OR: 1.47; 95% CI =
1.03 – 2.11) whereas mean GFR estimated by Cockcroft-Gault formula was significantly lower at 25 ± 7.4 vs. 41.0 ± 14.6
ml/minute (p = 0.001, OR = 0.89, 95% CI = 0.84 – 0.95) at the time of procedure in patients with CSCIN. Mean length of
hospital stay was significantly higher in this group compared to those without CIN, 9.0 ± 5.1 vs. 3.0 ± 3.2 days (p = 0.001,
OR = 1.31, 95% CI = 1.12 – 1.54). Multivariate analysis revealed low GFR (p = 0.001, OR = 0.88; 95% CI = 0.82 – 0.95)
and low ejection fraction (p = 0.03, OR = 0.20; 95% CI = 0.04 – 0.91) to be independent factors associated with
CSCIN. No significant differences were noted between the two groups in patients with hypertension, diabetes and
heart failure.
Conclusion: CSCIN is a significant concern in high risk groups despite prophylaxis. Patients with lower EF, cerebro-
vascular disease and low GFR at the time of procedure are more likely to have CIN.
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angiography, and its economic impact on patients at the
Aga Khan University Hospital, Karachi, Pakistan.
METHODOLOGY
The case records of patients who underwent coronary
angiography with or without intervention between
January 2005 and December 2007 at the Aga Khan
University Hospital, Karachi, Pakistan were retro-
spectively studied.
Patients who underwent non-emergent coronary
angiography with or without intervention and had a
serum creatinine level of 1.5 mg/dl or above at the time
of procedure were included in the study. Serum level
≥ 1.5 mg/dl was chosen to select only patients with
deranged renal function which are high risk with base-
line impairment. Moreover, only patients who received
non-ionic contrast were included for the purpose of
consistency.
Those patients were excluded who underwent emergent
coronary angiography or without adequate prophylaxis
against CIN, those who received ionic contrast, patients
with hemodynamic instability requiring vasopressor or
ionotropic support, patients with stage-V chronic kidney
disease (CKD), those who had repeat exposure to
contrast within 72 hours, and those who underwent
coronary artery by-pass surgery (CABG) within a week
following angiography.
Contrast induced nephropathy (CIN) was defined as an
absolute increase of 0.5 mg/dl or more in serum
creatinine from baseline at 48 or 72 hours following
exposure to contrast. “Clinically significant contrast
induced nephropathy” (CSCIN) was defined according
to the definition of the American College of Cardiology
National Cardiovascular Data registry as either doubling
of serum creatinine from baseline value within a week
following the procedure or need for emergency
hemodialysis after the procedure.12 Patients who had
CIN but did not meet the “clinically significant” definition
or no CIN were classified as having “clinically
insignificant contrast induced nephropathy” (CICIN).
Mean glomerular filtration rate (GRF) was estimated by
Cockcroft-Gault formula.13
The primary outcome measure was the frequency of
clinically significant contrast induced nephropathy while
the secondary outcome included evaluation of the risk
factors and co-morbidities associated with CSCIN, its
impact on length of stay and cost of hospitalization in
these patients.
A descriptive analysis was done for demographic and
clinical features and results are presented as mean ±
standard deviation and median [range] for skewed
variables for quantitative variables and number (percent-
age) for qualitative variables, respectively. In univariate
analysis, association between clinically significant CIN
and its risk factors were assessed by using the Chi-
square test or Fisher exact test where appropriate. For
comparison of continuous variables, independent
sample t-test for normally distributed variables and
Wilcoxon rank-sum test for non-normally distributed
variables was used to assess the difference of means.
To assess univariate associations between the out-
comes and potential co-variates, odds ratios (ORs) and
their 95% confidence intervals (CIs) were computed by
logistic regression analysis. All significant factors on
univariate analysis were considered for inclusion in the
multivariable logistic model.
All analyses were conducted by using the Statistical
Package for Social Sciences (SPSS) (release 19.0,
standard version, copyright © SPSS; 1989-02). All
p-values were two sided and considered as statistically
significant if < 0.05.
The study was approved by Ethical Review Committee
of the Aga Khan University Hospital, Karachi.
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Table I: Demographic and clinical characteristics of the patients studied.
Patients' characteristics n = 116
Age 64.0 ± 11.5
Gender
Males 84 (72%)
Females 32 (28%)
Diabetes mellitus 79 (68%)
Hypertension 104 (90%)
Heart failure 33 (28%)
Ejection fraction
< 30% 25 (22%)
30 – 55% 45 (39%)
> 55% 46 (39%)
Liver disease 2 (2%)
Cerebrovascular disease 10 (9%)
Peripheral vascular disease 5 (4%)
Use of medications at the time of procedure
Non-steroid 5 (4%)
ACE 70 (60%)
Diuretic 66 (57%)
Procedure detail
Diagnostic only 70 (60%)
Diagnostic plus PCI 46 (40%)
Type of contrast used
Ionic 0 (0%)
Non-ionic 116 (100%)
Volume of contrast (ml)
< 100 62 (53%)
> 100 54 (47%)
Creatinine after procedure 2.1 ± 1.2
Estimate GFR 38.7 ± 15
Creatinine 24 hours after procedure 2.0 ± 1.2
Creatinine 48 hours after procedure 2.2 ± 1.4
Peak serum creatinine 2.5 ± 1.5
Doubling of creatinine within week after procedure 10 (9%)
Need of hemodialysis 4 (3%)
Median length of stay (days) 2 (1-26)
Continuous variables are expressed as mean ± standard deviation and categorical variables
are expressed in number of patients (%). 
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Table II: Univariate analysis for the factors predicting the risk of clinically significant contrast induced nephropathy (CIN) (*p-values and Odds ratio
are calculated by comparing Groups 1 and 3).
Characteristics Group 1:  Group 2:  Group 3: p-value* Odds ratio
Clinically significant Clinically insignificant No CIN. N = 93 (95% C.I.)
CIN. N = 11 CIN. N = 12
Age (in years) 68.4 ± 11.3 63.5 ± 11.8 63.6 ± 11.6 0.20 1.03 (0.98-1.09)
Gender
Men 7 (64%) 7 (58%) 70 (75%) 0.41 1.0
Women 4 (36%) 5 (42%) 23 (25%) 1.73 (0.46-6.48)
Diabetes mellitus 8 (73%) 12 (100%) 59 (63%) 0.54 1.53 (0.38-6.18)
Hypertension 10 (91%) 11 (92%) 83 (89%) 0.86 1.20 (0.13-10.42)
Heart failure 4 (36%) 8 (67%) 21 (23%) 0.31 1.95 (0.52-7.34)
Cerebrovascular disease 5 (45.5%) 0 5 (5%) < 0.001 14.66 (3.30-65.08)
Liver disease 0 0 2 (2%) 0.62 N.S.
Peripheral vascular disease 0 2 (17%) 3 (3%) 0.54 N.S.
Ejection fraction
< 30% 5 (45.5%) 4 (33%) 16 (17%) 0.03 1.0
> 30% 6 (54.5%) 8 (67%) 77 (83%) 0.24 (0.06-0.91)
Estimate GFR (ml/min) 25.0 ± 7.4 32.0 ± 12.6 41.0 ± 14.6 0.001 0.89 (0.84-0.95)
Contrast volume
< 100 ml 5 (45.5%) 9 (75%) 48 (52%) 0.70 1.0
> 100 ml 6 (54.5%) 3 (25%) 45 (48%) 1.28 (0.36-4.48)
Baseline creatinine (mg/dl)
< 2.0 4 (36%) 5 (42%) 72 (77%) 0.008 1.0
> 2.0 7 (64%) 7 (58%) 21 (23%) 6 (1.60-22.48)
Mean baseline creatinine (mg/dl) 3.0 ± 1.5 2.5 ± 1.1 2.0 ± 1.1 0.03 1.47 (1.03-2.11)
Creatinine 24 hours after procedure (mg/dl) 3.0 ± 1.2 2.4 ± 1.0 1.9 ± 1.1 0.01 1.57 (1.07-2.30)
Creatinine 48 hours after procedure (mg/dl) 4.0 ± 2.0 3.1 ± 1.5 1.8 ± 1.1 0.002 2.10 (1.30-3.40)
Peak serum creatinine (mg/dl) 4.5 ± 1.8 3.7 ± 1.5 2.1 ± 1.2 < 0.001 1.95 (1.35-2.81)
Median length of hospital stay (days) 10 (2-16) 4 (1-13) 2 (1-26) 0.001 1.31(1.12-1.54)
N.S = Not significant.
Table III: Incidences of contrast induced nephropathy in Asian and Western countries.
Study Location of study Type of study Definition of CIN Number of Incidence  Need for dialysis Mean length of
patients of CIN (Number of  hospital stay in
patients) days (CIN vs. 
no CIN) 
Present study Karachi, Pakistan Retrospective 1. Rise in serum creatinine > 0.5 mg/dl 116 1.  17% 4 patients 9 vs. 3
2. Doubling of creatinine or need of 2.  9.5%
emergency hemodialysis
Soofi Karachi, Pakistan Retrospective Rise in serum creatinine > 0.5 mg/dl 200 8% Not given Not given
200619
Uddin et al. Karachi, Pakistan Retrospective Rise in serum creatinine > 0.5 mg/dl 115 9.65% Not given Not given
200518
Rahman et al. Dhaka, Bangladaesh Prospective Rise in serum creatinine ≥ 0.5 mg/dl or 245 24.08% Not given Not given
201020 ≥ 25%
Pakfetrat et al. Shiraz, Iran Prospective RIFLE* criteria 290 15.5% Not given Not given
20106
Senoo et al. Osaka, Japan Prospective Rise in serum creatinine ≥ 0.5 mg/dl or 335 28% Not given Not given
201021 ≥ 25%
Chong et al. Singapore Retrospective Rise in serum creatinine by ≥ 0.5 mg/dl 3036 7.3% Not given Not given
201022 or ≥ 25%
Ghani et al. Kuwait Prospective Rise in serum creatinine concentration of 247 5.52% Not given Not given
200923 ≥ 44.2 µmol/L within 48 hours after procedure
Shema et al. Nahariya, Israel Retrospective Rise in serum creatinine > 0.5 mg/dl 1111 4.6% Not given 24 vs. 13
20093
Marenzi et al. Milan, Italy Prospective Rise in serum creatinine > 0.5 mg/dl 208 19% Not given 13 vs. 8
20044
Rihal et al. Mayo clinic, USA Retrospective Rise in serum creatinine > 0.5 mg/dl 7586 3.3% Not given Not given
20022
*RIFLE = Risk, injury, failure, loss, and end-stage criteria;   CIN = Contrast induced nephropathy.
RESULTS
A total of 116 patients were included in the final analysis.
The mean age was 64 ± 12 years. Eighty four (72%)
patients were male. Overall prevalence of CIN i.e. serum
creatinine rise > 0.5 mg/dl was 17% (20 patients) while
that of CSCIN was 9.5% (11 patients). Baseline clinical
and procedural characteristics are given in Table I.
Comparison between the patients with CSCIN, CICIN and
no CIN is shown in Table II. The patients were divided into
three groups according to the ejection fraction: EF < 30%,
between 30 – 55% and > 55%. More patients with low EF
had CSCIN (45.5%) versus no CIN group (17%), p = 0.03.
Out of 93 patients with no CSCIN, only 17% had EF
< 30%, 34% between 30 – 55% and the majority (49%)
had > 55%. Five (45.5%) out of 11 patients with CSCIN
had a history of cerebrovascular disease compared to
only 5% in the patients with no CSCIN, p = < 0.001. Seven
(64%) out of 11 patients with CSCIN had a baseline serum
creatinine level greater than 2.0 mg/dl (p = 0.01). Mean
GFR was also found to be significantly lower at the time
of procedure in patients with CSCIN at 25.0 ± 7.4 versus
41.0 ± 14.6 ml/minute (p = 0.001). Out of 11 patients in
CSCIN group, 4 (36.4%) needed hemodialysis. The mean
cost of hospital stay in patients with CSCIN was found to
be Rs. 197,045 ± 156,955 as compared to Rs. 155,690 ±
160,545 in patients without CSCIN (p = 0.49) while the
mean length of hospital stay was higher in patients with
CSCIN (9.0 ± 5.1 days) as compared to their no CIN
counterparts (3.0 ± 3.2 days; p = 0.001).
A univariate analysis carried out by comparing patients
with CSCIN and no CIN revealed cerebrovascular
disease (OR: 14.66; 95% CI = 3.30 – 65.08), ejection
fraction < 30% (OR: 0.24; 95% CI = 0.06 – 0.91), mean
GFR (OR: 0.89; 95% CI = 0.84 – 0.95), baseline
creatinine > 2.0 mg/dl (OR: 6.0; 95% CI = 1.60 – 22.48),
creatinine 24 hours after procedure (OR: 1.57, 95% CI =
1.07 – 2.30), creatinine 48 hours after procedure (OR =
2.10; 95% CI = 1.30 – 3.40), peak serum creatinine (OR
= 1.95; 95% CI = 1.35 – 2.81) and length of hospital stay
(OR = 1.31; 95% CI = 1.12 – 1.54) to be statistically
significant (Table II).
Significant factors on univariate analysis were incorpo-
rated into multiple-logistic-regression model to evaluate
independent risk factors associated with CSCIN. Low
GFR (p = 0.001, OR = 0.88; 95% CI = 0.82 – 0.95) and
low ejection fraction i.e. < 30% (p = 0.03, OR = 0.20; 95%
CI = 0.04 – 0.91) were found to be the independent risk
factors associated with CSCIN.
DISCUSSION
Cardiovascular disease has been known to be much
more common in South Asian population, with a high
burden of morbidity and mortality.14 Risk factors such
as obesity, hypertension, diabetes, dyslipidemia and
sedentary lifestyle are highly prevalent in this part of
the world.15 Furthermore, reports of premature coronary
artery disease from this region are of great concern.16
With the rising incidence of coronary artery disease,
rates of diagnostic and therapeutic coronary angio-
graphies have also increased over the last few decades.
However, coronary angiography is not devoid of
complications, one of which is acute kidney injury or
contrast induced nephropathy (CIN).
The pathogenesis of CIN remains unclear. However, it
has been suggested to be multi-factorial, a combination
of direct toxicity to renal tubular cells and renal
ischaemia. Direct toxicity is attributed to generation of
free oxygen radicals after exposure to the contrast
media whereas ischaemia occurs due to vasoconstriction,
leading to medullary hypoxia. Down regulation of
vasodilators (nitric oxide and prostaglandins) along with
generation of vasoactive substances (adenosine and
endothelin) have also been implicated.17
To the best of authors' knowledge, only two studies have
been reported from Pakistan assessing the frequency of
CIN in patients undergoing coronary angiography.18,19
The criterion used to define CIN in these studies was a
rise in serum creatinine of > 0.5 mg/dl from baseline.
Using this definition, the percentage of patients with CIN
was much higher in this study; 17% compared to 9.6%
and 8% reported in the prior two studies, respectively.
These studies also did not evaluate risk factors such as
reduced left ventricular ejection fraction, prior history of
cerebrovascular accidents, peripheral vascular disease
and liver disease which might be associated with CIN.
Among the 116 CKD patients studied, 9.5% developed
'clinically significant' CIN, which was defined as doubling
of serum creatinine or need for hemodialysis within 7
days of coronary angiogram. Contrasting incidence has
been reported in the past.2-4,6 Table III compares the
recently published regional and international data on
incidence of contrast induced nephropathy in patients
undergoing coronary angiograms.18-23 The variability is
most likely multi-factorial; due to different definitions
being used, variable cohort size, diverse patient
populations, single centre vs. multicentre studies etc.
Multiple risk factors for CIN have been identified and
thoroughly looked into in the past. Of these, reduced
GFR and low ejection fraction are the two important
ones. In this study, low ventricular ejection fraction (EF)
was found to be associated with clinically significant
CIN, which has been reported previously.4,22,24 A lower
EF leads to hypo-perfusion of the organs including
kidneys, leading to ischaemic damage which subse-
quently results in the formation of free oxygen radicals,
vasoconstriction and endothelial activation that directly
damages the kidney.22 A study reported EF < 40% in
50% of the patients with CIN relative to 11% without
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CIN (p = < 0.0001).4 Another survey from Mayo Clinic
showed decreased mean LVEF in patients with acute
kidney injury who died during the course of their stay in
the hospital.2 This was further confirmed by Chong et al.
who reported that abnormal LVEF resulted in high
mortality rate in patients, 6.4% vs. 2.0%.24
Presence of underlying reduced GFR is by far the most
important risk factor for development of CIN.6,24 Serum
creatinine levels solely are extensively used to estimate
the renal function. However, several studies have found
deranged GFR values even in patients with normal
creatinine levels.25 This is due to the fact that reduction
in muscle mass leads to reduced serum creatinine level
and though it is within normal limits, GFR might be
decreased significantly. Chong et al. found a rise from
7.4% to 34.0% in the incidence of CIN with a decrease
in GFR from 30 – 60 to < 30, respectively. Moreover,
patients with GFR < 30 were resistant to prophylactic
treatment.24 The present results are compatible with
the literature which showed that patients with CIN
had almost doubled mean creatinine levels and 1.5
folds reduced GFR indicating severe baseline renal
insufficiency.
CIN is associated with a longer duration of hospital stay
due to its more complicated clinical course. In one study,
a 1.5 fold increase in hospital stay was noted while other
reported twice the increase in duration.3,4 The presently
reported patients with clinically significant CIN had a
three folds increase in the hospital stay compared to
those without CIN. Moreover, an increasing trend in the
cost of hospital stay was also observed which, however,
was not significant. This could be due to several
confounding factors such as admission to high definition
units vs. wards vs. private rooms.
There are several limitations of the study which need to
be addressed. Being a retrospective analysis has its
engraved bias. This study cohort formed a small
population which might underestimate the risk factors.
Since it is a single centre study, it cannot be represen-
tative of the general population. The study was
conducted at a private institute which mainly caters to
middle to higher socioeconomic class and hence, results
may not be generalized to poor socioeconomic classes.
Prospective analysis with a control group would help to
limit these shortcomings.
CONCLUSION
Clinically significant contrast induced nephropathy is a
major concern for increase in morbidity in this high risk
population despite adequate prophylaxis. Patients with
poor EF, cerebrovascular disease and reduced GFR at
the time of angiography are more likely to develop
clinically significant CIN. 
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